{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:26:12Z","timestamp":1770150372978,"version":"3.49.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00301","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T14:01:59Z","timestamp":1582639319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Darius","family":"H\u00e4usler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Torke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","article-title":"Vitamin D deficiency in systemic lupus erythematosus","volume":"5","author":"Kamen","year":"2006","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/ard.2008.093476","article-title":"Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus","volume":"68","author":"Cutolo","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/art.24790","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?","volume":"61","author":"Gatenby","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis","volume":"87","author":"Lemire","year":"1991","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/00005072-199608000-00006","article-title":"1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis","volume":"55","author":"Nataf","year":"1996","journal-title":"J Neuropathol Exp Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","article-title":"1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Nashold","year":"2000","journal-title":"J Neuroimmunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","article-title":"Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice","volume":"175","author":"Spach","year":"2005","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/brain\/awz190","article-title":"High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium","volume":"142","author":"H\u00e4usler","year":"2019","journal-title":"Brain."},{"key":"B14","first-page":"57","article-title":"The vitamin D hormone and its nuclear receptor: molecular actions and disease states","volume":"154","author":"Haussler","year":"1997","journal-title":"J Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","article-title":"The nuclear vitamin D receptor: biological and molecular regulatory properties revealed","volume":"13","author":"Haussler","year":"1998","journal-title":"J Bone Miner Res."},{"key":"B16","first-page":"89","article-title":"Vitamin D-regulated gene expression","volume":"3","author":"Darwish","year":"1993","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/00365513.2012.682862","article-title":"Vitamin D and immune function: autocrine, paracrine or endocrine?","volume":"243","author":"Hewison","year":"2012","journal-title":"Scand J Clin Lab Invest Suppl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","article-title":"Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation","volume":"57","author":"Bhalla","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/endo-122-4-1224","article-title":"Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells","volume":"122","author":"Clemens","year":"1988","journal-title":"Endocrinology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0169-328X(92)90032-7","article-title":"Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels","volume":"13","author":"Sutherland","year":"1992","journal-title":"Brain Res Mol Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0169-328X(94)90119-8","article-title":"1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells","volume":"24","author":"Neveu","year":"1994","journal-title":"Brain Res Mol Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0165-3806(95)00204-9","article-title":"1,25-Dihydroxyvitamin D(3) receptors in developing dorsal root ganglia of fetal rats","volume":"92","author":"Johnson","year":"1996","journal-title":"Brain Res Dev Brain Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#","article-title":"1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro","volume":"53","author":"Cornet","year":"1998","journal-title":"J Neurosci Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0006-8993(98)00565-4","article-title":"1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo","volume":"804","author":"Veenstra","year":"1998","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0891-0618(99)00002-2","article-title":"Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord","volume":"16","author":"Prufer","year":"1999","journal-title":"J Chem Neuroanat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO;2-Y","article-title":"Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3)","volume":"31","author":"Baas","year":"2000","journal-title":"Glia."},{"key":"B29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0306-4522(01)00049-5","article-title":"Evidence of functional vitamin D receptors in rat hippocampus","volume":"104","author":"Langub","year":"2001","journal-title":"Neuroscience."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science."},{"key":"B31","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.136.8.2734","article-title":"1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production","volume":"136","author":"Provvedini","year":"1986","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0165-5728(01)00360-5","article-title":"Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis","volume":"119","author":"Nashold","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D suppresses Th17 cytokine production by inducing C\/EBP homologous protein (CHOP) expression","volume":"285","author":"Chang","year":"2010","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1074\/jbc.M110.163790","article-title":"Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells","volume":"286","author":"Palmer","year":"2011","journal-title":"J Biol Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J Exp Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Mult Scler."},{"key":"B38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","article-title":"Cytokine profile in patients with multiple sclerosis following vitamin D supplementation","volume":"134","author":"Mahon","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-Hanninen","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2377-13-60","article-title":"Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties","volume":"13","author":"Golan","year":"2013","journal-title":"BMC Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon beta-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1212\/NXI.0000000000000597","article-title":"Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: a meta-analysis","volume":"265","author":"Mclaughlin","year":"2018","journal-title":"J Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jns.2014.08.019","article-title":"Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D","volume":"346","author":"Fragoso","year":"2014","journal-title":"J Neurol Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1210\/jc.2015-4013","article-title":"Vitamin D 20,000 IU per week for 5 years does not prevent progression from prediabetes to diabetes","volume":"101","author":"Jorde","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","article-title":"Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial","volume":"258","author":"Steffensen","year":"2011","journal-title":"J Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-156-2-201201170-00004","article-title":"High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial","volume":"156","author":"Lehouck","year":"2012","journal-title":"Ann Intern Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/archneurol.2011.1199","article-title":"Severe hypercalcemia following vitamin D supplementation in a patient with multiple sclerosis: a note of caution","volume":"69","author":"Marcus","year":"2012","journal-title":"Arch Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.molimm.2018.12.001","article-title":"Correlation of different cellular assays to analyze T cell-related cytokine profiles in vitamin D3-supplemented patients with multiple sclerosis","volume":"105","author":"Rolf","year":"2019","journal-title":"Mol Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e15235","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis","volume":"5","author":"Smolders","year":"2010","journal-title":"PLoS ONE."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/eurheartj\/ehx235","article-title":"Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4,000 IU vitamin D daily","volume":"38","author":"Zittermann","year":"2017","journal-title":"Eur Heart J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/nu7095383","article-title":"Regulation of dendritic cell function by vitamin D","volume":"7","author":"Barragan","year":"2015","journal-title":"Nutrients."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3945\/ajcn.116.134981","article-title":"Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis","volume":"104","author":"Malihi","year":"2016","journal-title":"Am J Clin Nutr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsbmb.2018.12.002","article-title":"Adverse events from large dose vitamin D supplementation taken for one year or longer","volume":"188","author":"Malihi","year":"2019","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/rheumatology\/36.6.712","article-title":"Severe hypercalcaemia syndrome with daily low-dose vitamin D supplementation","volume":"36","author":"Jansen","year":"1997","journal-title":"Br J Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"CD000227","DOI":"10.1002\/14651858.CD000227.pub4","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","volume":"4","author":"Avenell","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"CD007470","DOI":"10.1002\/14651858.CD007470.pub3","article-title":"Vitamin D supplementation for prevention of mortality in adults","volume":"1","author":"Bjelakovic","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity","volume":"88","author":"Jones","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/187152013804487290","article-title":"Safety issues of vitamin D supplementation","volume":"13","author":"Zittermann","year":"2013","journal-title":"Anticancer Agents Med Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/brain\/awz389","article-title":"Reply: neither human nor mouse is hypercalcaemic with 250 nmol\/l 25-hydroxyvitamin D","volume":"143","author":"H\u00e4usler","year":"2019","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/jn\/129.11.1966","article-title":"Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice","volume":"129","author":"Cantorna","year":"1999","journal-title":"J Nutr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature04702","article-title":"A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function","volume":"441","author":"Feske","year":"2006","journal-title":"Nature."},{"key":"B65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.clim.2010.01.011","article-title":"Immunodeficiency due to mutations in ORAI1 and STIM1","volume":"135","author":"Feske","year":"2010","journal-title":"Clin Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","article-title":"TCR signaling: mechanisms of initiation and propagation","volume":"43","author":"Courtney","year":"2018","journal-title":"Trends Biochem Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","article-title":"Regulatory mechanisms in T cell receptor signaling","volume":"18","author":"Gaud","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41232-019-0095-z","article-title":"T cell receptor signaling for gammadeltaT cell development","volume":"39","author":"Muro","year":"2019","journal-title":"Inflamm Regen."},{"key":"B69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.f.220","article-title":"Calcium signaling in immune cells","volume":"10","author":"Vig","year":"2009","journal-title":"Nat Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.coi.2008.04.004","article-title":"Calcium signaling in lymphocytes","volume":"20","author":"Oh-Hora","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fimmu.2013.00432","article-title":"The regulation of calcium homeostasis in T lymphocytes","volume":"4","author":"Toldi","year":"2013","journal-title":"Front Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1469-7793.2000.00553.x","article-title":"Quantification of calcium signal transmission from sarco-endoplasmic reticulum to the mitochondria","volume":"529","author":"Pacher","year":"2000","journal-title":"J Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fimmu.2013.00324","article-title":"Modulation of T cell metabolism and function through calcium signaling","volume":"4","author":"Fracchia","year":"2013","journal-title":"Front Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2000672","article-title":"Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling","volume":"3","author":"Bogeski","year":"2010","journal-title":"Sci Signal."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2010.05.005","article-title":"Activation of store-operated I(CRAC) by hydrogen peroxide","volume":"48","author":"Grupe","year":"2010","journal-title":"Cell Calcium."},{"key":"B76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.201004152","article-title":"S-glutathionylation activates STIM1 and alters mitochondrial homeostasis","volume":"190","author":"Hawkins","year":"2010","journal-title":"J Cell Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4049\/jimmunol.1302586","article-title":"Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation","volume":"192","author":"Kim","year":"2014","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2012.12.011","article-title":"Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions","volume":"54","author":"Chen","year":"2013","journal-title":"Mol Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e82944","DOI":"10.1371\/journal.pone.0082944","article-title":"Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function","volume":"8","author":"Cox","year":"2013","journal-title":"PLoS ONE."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0742-8413(92)90219-W","article-title":"Sensitivities of Achatina giant neurones to putative amino acid neurotransmitters","volume":"103","author":"Takeuchi","year":"1992","journal-title":"Comp Biochem Physiol C."},{"key":"B81","first-page":"415","article-title":"Drug addiction. Part III. Pharmacotherapy of addiction","volume":"53","author":"Vetulani","year":"2001","journal-title":"Pol J Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000495425","article-title":"Targeting voltage-dependent calcium channels with pregabalin exerts a direct neuroprotective effect in an animal model of multiple sclerosis","volume":"26","author":"Hundehege","year":"2018","journal-title":"Neurosignals."},{"key":"B83","doi-asserted-by":"publisher","first-page":"E3295","DOI":"10.1073\/pnas.1620052114","article-title":"Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis","volume":"114","author":"Schampel","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B84","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ana.410170202","article-title":"Antispasticity drugs: mechanisms of action","volume":"17","author":"Davidoff","year":"1985","journal-title":"Ann Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2004.05.023","article-title":"Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis","volume":"189","author":"Brand-Schieber","year":"2004","journal-title":"Exp Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/EC-18-0432","article-title":"Vitamin D testing and treatment: a narrative review of current evidence","volume":"8","author":"Pilz","year":"2019","journal-title":"Endocr Connect."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:05:17Z","timestamp":1695830717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2020.00301"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00301","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"301"}}